Timothy L. Moore, EVP, Technical Operations at Kite Pharma, Inc. (KITE), sold 12,000 shares at $110.10 ($1.3M) on 2017-08-03, disclosed to the SEC on 2017-08-04.
Open-market sale of $1.3M KITE by EVP, Technical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.05 | 5,131 | $565K | 42.8% |
| 2 | $110.05 | 5,131 | $565K | 42.8% |
| 3 | $110.10 | 869 | $96K | 7.2% |
| 4 | $110.10 | 869 | $96K | 7.2% |
| Total | $110.06 avg | 12,000 | $1.3M | 100% |
| Filing → |
| CERS | BUY | 2020-02-03 | $15K | — | Filing → |
| KITE | SELL | 2017-09-27 | $2.8M | — | Filing → |
| KITE | SELL | 2017-08-03 | $2.5M | — | Filing → |